HealthTree Logo
search more_vert
close
person Sign In / Create Account
Harnessing the Immune System in Relapsed/Refractory AML with Dr. John Reagan, Rhode Island Hospital
Harnessing the Immune System in Relapsed/Refractory AML with Dr. John Reagan, Rhode Island Hospital image
HealthTree Podcast for AML
event Sep 30, 2021 / 12:00PM CDT

Event Description

IF YOU WOULD PREFER TO JOIN THE SHOW BY PHONE, PLEASE CALL (515) 602-9728

*you need to join by phone if you want to ask the doctor questions.

The use of the immune system to treat patients with AML is being heavily pursued as a strategy to more effectively fight AML and give patients with relapsed or refractory disease a better chance at achieving remission or a cure.

Immunotherapy in the form of allogeneic stem cell transplant has been a foundation of curative therapy in AML since the 1970s. While the effectiveness and tolerability of stem cell transplant has improved over the years, significant limitations still exist, warranting the development of new and improved immunotherapy options. 

Join us live September 30th at 12 PM Central to learn from Dr. John Reagan, an AML expert from Rhode Island Hospital, about what steps you can take if you have relapsed or refractory AML. He will be discussing what immunotherapy is, it’s current use in AML and his open clinical trial looking at whether the FDA approved drug Gemtuzumab, followed by an infusion of blood cells called leukocytes from a donor, can stimulate the immune system to potentially fight AML.

Schedule & Agenda

person
Welcome
12:00PM
Welcome, announcements and introduction
person
Interview
12:05PM
Dr. Reagan answers questions about relapsed/refractory AML, immunotherapy treatment options and his open clinical trial title "Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia"
person
Q&A
12:50PM
Audience is able to call in to the radio show (515) 602-9728 to ask Dr. Reagan questions about what was discussed during our interview today and his open clinical trial.

Speakers & Moderators

The panelist John Reagan
John Reagan
Providence, Rhode Island

Director of Hematology, Rhode Island Hospital

Read Bio
The panelist Katie Braswell
Katie Braswell
Dallas, Texas

Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors, and travel to new places.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Get the latest thought leadership on Acute Myeloid Leukemia delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Acute Myeloid Leukemia Newsletter" for Acute Myeloid Leukemia news, life with Acute Myeloid Leukemia stories, Acute Myeloid Leukemia clinical trials, Acute Myeloid Leukemia 101 articles and events with Acute Myeloid Leukemia experts.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Abbvie
Astellas Pharma
Servier

Follow Us

facebook twitter